BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.260
-0.030 (-0.91%)
Aug 3, 2026, 4:00 PM EDT - Market closed
BioAtla Market Cap
BioAtla has a market cap or net worth of $5.41 million as of August 3, 2026. Its market cap has decreased by -71.94% in one year.
Market Cap
5.41M
Enterprise Value
9.54M
1-Year Change
-71.94%
Ranking
Category
Stock Price
$3.26
ChartMarket Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $5.41M, a decrease of -99.94%. That is a compound annual growth rate of -73.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 5.41M | -83.86% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curanex Pharmaceuticals | 5.82M |
| Xenetic Biosciences | 5.81M |
| Enveric Biosciences | 5.78M |
| Cadrenal Therapeutics | 5.77M |
| AIM ImmunoTech | 5.60M |
| Soligenix | 5.54M |
| NuCana | 5.49M |
| Evogene | 5.28M |